{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:56:41Z","timestamp":1791932201315,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,4,22]],"date-time":"2011-04-22T00:00:00Z","timestamp":1303430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s00223-011-9485-1","type":"journal-article","created":{"date-parts":[[2011,4,21]],"date-time":"2011-04-21T07:09:05Z","timestamp":1303369745000},"page":"511-520","source":"Crossref","is-referenced-by-count":25,"title":["Monthly Administration of a Novel PTH-Collagen Binding Domain Fusion Protein is Anabolic in Mice"],"prefix":"10.1007","volume":"88","author":[{"given":"Tulasi","family":"Ponnapakkam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Katikaneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ponnapakkam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hirofumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. J.","family":"Suva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sakon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. C.","family":"Gensure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,22]]},"reference":[{"key":"9485_CR1","unstructured":"National Osteoporosis Foundation (2009) About osteoporosis. Bone health basics. Why bone health is important. http:\/\/www.nof.org\/aboutosteoporosis\/bonebasics\/whybonehealth"},{"key":"9485_CR2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","volume":"22","author":"R Burge","year":"2007","unstructured":"Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005\u20132025. J Bone Miner Res 22:465\u2013475","journal-title":"J Bone Miner Res"},{"key":"9485_CR3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial. JAMA 288:321\u2013333","journal-title":"JAMA"},{"key":"9485_CR4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/ar.1091930309","volume":"193","author":"SC Miller","year":"1979","unstructured":"Miller SC, Jee WS (1979) The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat. Anat Rec 193:439\u2013462","journal-title":"Anat Rec"},{"key":"9485_CR5","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/1529-0131(199906)42:6<1246::AID-ANR22>3.0.CO;2-U","volume":"42","author":"MC Hochberg","year":"1999","unstructured":"Hochberg MC, Ross PD, Black D, Cummings SR, Genant HK, Nevitt MC, Barrett-Connor E, Musliner T, Thompson D (1999) Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group. Arthritis Rheum 42:1246\u20131254","journal-title":"Arthritis Rheum"},{"key":"9485_CR6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2147\/CIA.S3177","volume":"3","author":"J Iwamoto","year":"2008","unstructured":"Iwamoto J, Sato Y, Takeda T, Matsumoto H (2008) Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature. Clin Interv Aging 3:483\u2013489","journal-title":"Clin Interv Aging"},{"key":"9485_CR7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11154-006-9007-z","volume":"7","author":"M Girotra","year":"2006","unstructured":"Girotra M, Rubin MR, Bilezikian JP (2006) The use of parathyroid hormone in the treatment of osteoporosis. Rev Endocr Metab Disord 7:113\u2013121","journal-title":"Rev Endocr Metab Disord"},{"key":"9485_CR8","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"9485_CR9","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.coph.2005.07.004","volume":"5","author":"KE Poole","year":"2005","unstructured":"Poole KE, Reeve J (2005) Parathyroid hormone\u2014a bone anabolic and catabolic agent. Curr Opin Pharmacol 5:612\u2013617","journal-title":"Curr Opin Pharmacol"},{"key":"9485_CR10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11914-008-0003-y","volume":"6","author":"PD Miller","year":"2008","unstructured":"Miller PD (2008) Safety of parathyroid hormone for the treatment of osteoporosis. Curr Osteoporos Rep 6:12\u201316","journal-title":"Curr Osteoporos Rep"},{"key":"9485_CR11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/01926230490462138","volume":"32","author":"JL Vahle","year":"2004","unstructured":"Vahle JL, Long GG, Sandusky G, Westmore M, Ma YL, Sato M (2004) Bone neoplasms in F344 rats given teriparatide [rhPTH(1\u201334)] are dependent on duration of treatment and dose. Toxicol Pathol 32:426\u2013438","journal-title":"Toxicol Pathol"},{"key":"9485_CR12","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1359\/jbmr.080807","volume":"23","author":"JL Vahle","year":"2008","unstructured":"Vahle JL, Zuehlke U, Schmidt A, Westmore M, Chen P, Sato M (2008) Lack of bone neoplasms and persistence of bone efficacy in cynomolgus macaques after long-term treatment with teriparatide [rhPTH(1\u201334)]. J Bone Miner Res 23:2033\u20132039","journal-title":"J Bone Miner Res"},{"key":"9485_CR13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1359\/jbmr.061111","volume":"22","author":"KD Harper","year":"2007","unstructured":"Harper KD, Krege JH, Marcus R, Mitlak BH (2007) Osteosarcoma and teriparatide? J Bone Miner Res 22:334","journal-title":"J Bone Miner Res"},{"key":"9485_CR14","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00198-009-1004-0","volume":"21","author":"V Subbiah","year":"1041","unstructured":"Subbiah V, Madsen VS, Raymond AK, Benjamin RS, Ludwig JA (1041) Of mice and men: divergent risks of teriparatide-induced osteosarcoma. Osteoporos Int 21:1041\u20131045","journal-title":"Osteoporos Int"},{"key":"9485_CR15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11914-008-0005-9","volume":"6","author":"JP Bilezikian","year":"2008","unstructured":"Bilezikian JP (2008) Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window. Curr Osteoporos Rep 6:24\u201330","journal-title":"Curr Osteoporos Rep"},{"key":"9485_CR16","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1359\/jbmr.070616","volume":"22","author":"PJ Kostenuik","year":"2007","unstructured":"Kostenuik PJ, Ferrari S, Pierroz D, Bouxsein M, Morony S, Warmington KS, Adamu S, Geng Z, Grisanti M, Shalhoub V, Martin S, Biddlecome G, Shimamoto G, Boone T, Shen V, Lacey D (2007) Infrequent delivery of a long-acting PTH-Fc fusion protein has potent anabolic effects on cortical and cancellous bone. J Bone Miner Res 22:1534\u20131547","journal-title":"J Bone Miner Res"},{"key":"9485_CR17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1172\/JCI11296","volume":"107","author":"LM Calvi","year":"2001","unstructured":"Calvi LM, Sims NA, Hunzelman JL, Knight MC, Giovannetti A, Saxton JM, Kronenberg HM, Baron R, Schipani E (2001) Activated parathyroid hormone\/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest 107:277\u2013286","journal-title":"J Clin Invest"},{"key":"9485_CR18","doi-asserted-by":"crossref","first-page":"28650","DOI":"10.1074\/jbc.M100717200","volume":"276","author":"RC Gensure","year":"2001","unstructured":"Gensure RC, Gardella TJ, Juppner H (2001) Multiple sites of contact between the carboxyl-terminal binding domain of PTHrP-(1\u201336) analogs and the amino-terminal extracellular domain of the PTH\/PTHrP receptor identified by photoaffinity cross-linking. J Biol Chem 276:28650\u201328658","journal-title":"J Biol Chem"},{"key":"9485_CR19","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1021\/bi051833a","volume":"45","author":"A Wittelsberger","year":"2006","unstructured":"Wittelsberger A, Corich M, Thomas BE, Lee BK, Barazza A, Czodrowski P, Mierke DF, Chorev M, Rosenblatt M (2006) The mid-region of parathyroid hormone (1\u201334) serves as a functional docking domain in receptor activation. Biochemistry 45:2027\u20132034","journal-title":"Biochemistry"},{"key":"9485_CR20","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1210\/en.142.2.704","volume":"142","author":"KB Jonsson","year":"2001","unstructured":"Jonsson KB, John MR, Gensure RC, Gardella TJ, Juppner H (2001) Tuberoinfundibular peptide 39 binds to the parathyroid hormone (PTH)\/PTH-related peptide receptor, but functions as an antagonist. Endocrinology 142:704\u2013709","journal-title":"Endocrinology"},{"key":"9485_CR21","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1074\/jbc.273.6.3643","volume":"273","author":"O Matsushita","year":"1998","unstructured":"Matsushita O, Jung CM, Minami J, Katayama S, Nishi N, Okabe A (1998) A study of the collagen-binding domain of a 116-kDa Clostridium histolyticum collagenase. J Biol Chem 273:3643\u20133648","journal-title":"J Biol Chem"},{"key":"9485_CR22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/03008200109016842","volume":"42","author":"T Toyoshima","year":"2001","unstructured":"Toyoshima T, Matsushita O, Minami J, Nishi N, Okabe A, Itano T (2001) Collagen-binding domain of a Clostridium histolyticum collagenase exhibits a broad substrate spectrum both in-vitro and in-vivo. Connect Tissue Res 42:281\u2013290","journal-title":"Connect Tissue Res"},{"key":"9485_CR23","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1074\/jbc.M003450200","volume":"276","author":"O Matsushita","year":"2001","unstructured":"Matsushita O, Koide T, Kobayashi R, Nagata K, Okabe A (2001) Substrate recognition by the collagen-binding domain of Clostridium histolyticum class I collagenase. J Biol Chem 276:8761\u20138770","journal-title":"J Biol Chem"},{"key":"9485_CR24","doi-asserted-by":"crossref","first-page":"10868","DOI":"10.1074\/jbc.M807684200","volume":"284","author":"ST Philominathan","year":"2009","unstructured":"Philominathan ST, Koide T, Hamada K, Yasui H, Seifert S, Matsushita O, Sakon J (2009) Unidirectional binding of clostridial collagenase to triple helical substrates. J Biol Chem 284:10868\u201310876","journal-title":"J Biol Chem"},{"key":"9485_CR25","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/emboj\/cdg172","volume":"22","author":"JJ Wilson","year":"2003","unstructured":"Wilson JJ, Matsushita O, Okabe A, Sakon J (2003) A bacterial collagen-binding domain with novel calcium-binding motif controls domain orientation. EMBO J 22:1743\u20131752","journal-title":"EMBO J"},{"key":"9485_CR26","doi-asserted-by":"crossref","first-page":"28861","DOI":"10.1074\/jbc.272.46.28861","volume":"272","author":"C Bergwitz","year":"1997","unstructured":"Bergwitz C, Jusseaume SA, Luck MD, Juppner H, Gardella TJ (1997) Residues in the membrane-spanning and extracellular loop regions of the parathyroid hormone (PTH)-2 receptor determine signaling selectivity for PTH and PTH-related peptide. J Biol Chem 272:28861\u201328868","journal-title":"J Biol Chem"},{"key":"9485_CR27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/15376510802499030","volume":"19","author":"R Katikaneni","year":"2009","unstructured":"Katikaneni R, Ponnapakkam A, Miller E, Ponnapakkam T, Gensure RC (2009) A new technique for precisely and accurately measuring lumbar spine bone mineral density in mice using clinical dual energy X-ray absorptiometry (DXA). Toxicol Mech Methods 19:225\u2013231","journal-title":"Toxicol Mech Methods"},{"key":"9485_CR28","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1128\/IAI.71.9.5371-5375.2003","volume":"71","author":"E Tamai","year":"2003","unstructured":"Tamai E, Ishida T, Miyata S, Matsushita O, Suda H, Kobayashi S, Sonobe H, Okabe A (2003) Accumulation of Clostridium perfringens epsilon-toxin in the mouse kidney and its possible biological significance. Infect Immun 71:5371\u20135375","journal-title":"Infect Immun"},{"key":"9485_CR29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1348-0421.2005.tb03726.x","volume":"49","author":"S Shimamoto","year":"2005","unstructured":"Shimamoto S, Tamai E, Matsushita O, Minami J, Okabe A, Miyata S (2005) Changes in ganglioside content affect the binding of Clostridium perfringens epsilon-toxin to detergent-resistant membranes of Madin-Darby canine kidney cells. Microbiol Immunol 49:245\u2013253","journal-title":"Microbiol Immunol"},{"key":"9485_CR30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/en.2003-0746","volume":"145","author":"SO Rzonca","year":"2004","unstructured":"Rzonca SO, Suva LJ, Gaddy D, Montague DC, Lecka-Czernik B (2004) Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology 145:401\u2013406","journal-title":"Endocrinology"},{"key":"9485_CR31","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1359\/jbmr.1999.14.7.1167","volume":"14","author":"T Hildebrand","year":"1999","unstructured":"Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P (1999) Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 14:1167\u20131174","journal-title":"J Bone Miner Res"},{"key":"9485_CR32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bone.2005.07.028","volume":"38","author":"CM Bagi","year":"2006","unstructured":"Bagi CM, Hanson N, Andresen C, Pero R, Lariviere R, Turner CH, Laib A (2006) The use of micro-CT to evaluate cortical bone geometry and strength in nude rats: correlation with mechanical testing, pQCT and DXA. Bone 38:136\u2013144","journal-title":"Bone"},{"key":"9485_CR33","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra067395","volume":"357","author":"E Canalis","year":"2007","unstructured":"Canalis E, Giustina A, Bilezikian JP (2007) Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 357:905\u2013916","journal-title":"N Engl J Med"},{"key":"9485_CR34","first-page":"254","volume":"24","author":"P Goldhaber","year":"1964","unstructured":"Goldhaber P, Roth SI, Cirulis G (1964) the effect of parathyroid and other human tumors and tissues on bone resorption in tissue culture. Cancer Res 24:254\u2013259","journal-title":"Cancer Res"},{"key":"9485_CR35","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bbrc.2004.11.069","volume":"328","author":"RC Gensure","year":"2005","unstructured":"Gensure RC, Gardella TJ, Juppner H (2005) Parathyroid hormone and parathyroid hormone\u2013related peptide, and their receptors. Biochem Biophys Res Commun 328:666\u2013678","journal-title":"Biochem Biophys Res Commun"},{"key":"9485_CR36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1043-2760(01)00489-1","volume":"12","author":"EK Barbehenn","year":"2001","unstructured":"Barbehenn EK, Lurie P, Wolfe SM (2001) Osteosarcoma risk in rats using PTH 1\u201334. Trends Endocrinol Metab 12:383","journal-title":"Trends Endocrinol Metab"},{"key":"9485_CR37","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1359\/JBMR.051017","volume":"21","author":"A Iida-Klein","year":"2006","unstructured":"Iida-Klein A, Hughes C, Lu SS, Moreno A, Shen V, Dempster DW, Cosman F, Lindsay R (2006) Effects of cyclic versus daily hPTH(1\u201334) regimens on bone strength in association with BMD, biochemical markers, and bone structure in mice. J Bone Miner Res 21:274\u2013282","journal-title":"J Bone Miner Res"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-011-9485-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-011-9485-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-011-9485-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T11:41:00Z","timestamp":1558698060000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-011-9485-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,22]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["9485"],"URL":"https:\/\/doi.org\/10.1007\/s00223-011-9485-1","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,22]]}}}